Trump bought these health care stocks in 2026; should you?

President Donald Trump has been trading wellness attraction stocks unusually often successful 2026. 

Across the archetypal 3 months of the year, his accounts ran 377 abstracted wellness attraction trades, a premix of buys and sells, worthy astatine slightest $13 cardinal and arsenic overmuch arsenic $37 cardinal by the disclosed ranges.

That enactment sits wrong a overmuch larger pattern. 

The accounts made 3,642 full transactions betwixt January 6 and March 30, CBS News reported aft analyzing the president's latest fiscal disclosure.

The Trump Organization says extracurricular advisers tally the accounts and that the president and his household play nary relation successful the investments.

For a regular investor, the absorbing question is whether Trump's most-traded wellness attraction names are really worthy owning close now.

How Trump's most-traded wellness attraction stocks performed successful 2026

Most of Trump's heavy traded wellness attraction names are down. A fewer person delivered standout gains. Knowing which is which, and why, is the full game.

Here is the ranked picture, by fig of trades, with the disclosed dollar scope and year-to-date (YTD) terms determination for each.

Trump's 10 most-traded wellness attraction stocks successful 2026 astatine a glance

Source: commercialized counts and dollar ranges are from the president's fiscal disclosure || year-to-date prices were compiled by me.

UnitedHealth's scope stretches widest due to the fact that of 1 ample azygous merchantability disclosed successful the "$1,000,001 - $5,000,000" bracket, layered connected apical of galore smaller transactions.

Now to the portion that matters for your money: what is really moving each stock.

Why UnitedHealth and Humana are the group's biggest winners

UnitedHealth is the clearest comeback communicative here.

The banal is up much than 19% YTD aft a brutal agelong successful 2025 that sent the banal crashing. 

CEO Andrew Witty stepped down successful May 2025, the committee brought backmost erstwhile main Stephen Hemsley, and the Department of Justice opened an probe into the company's Medicare billing practices. All of which contributed to the company's decline.